MedPath
HSA Approval

NOVOMIN TABLET 50 mg

SIN03403P

NOVOMIN TABLET 50 mg

NOVOMIN TABLET 50 mg

June 16, 1989

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A04AD

其它镇吐药

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

DIMENHYDRINATE

50 mg

Dimenhydrinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOVOMIN TABLET 50 mg - HSA Approval | MedPath